Verdi Oncology Acquires NexGen Oncology

We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi Cancer and Research Center of Texas. Terms of the transaction were not disclosed.

The center, led by Dr. Jivesh Sharma and Dr. Amy Cripps, will provide high quality medical oncology care and early phase clinical trials to patients in the greater Dallas-Fort Worth market. The new partnership marks Verdi’s entry into its fourth market since the company’s inception in 2018, following expansions into Indiana, Michigan and Tennessee.

Verdi Oncology, Inc., headquartered in Nashville, TN, is an oncology practice and clinical research management company focused on partnering with high-quality oncology physicians and practices.

 

You Also May Be Interested In:

  • Representation of Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC), a company that provides goods and services associated with the disposition and memorialization of human remains

    We represented Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC),...
    Client Type: Private Company
  • Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion

    We represented WellCare Health Plans, Inc. in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion. The combined company...
    Client Type: Public Company
  • Representation of LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure installations, to MiddleGround Capital

    We represented LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure...
    Client Type: Private Company